Here, we show that loss of ABHD5 activates c-Met to increase and sustain the stemness of CRC cells in a non-canonical and metabolic independent manner and is synthetic lethal with c-Met inhibition. The gene discussed is ABHD5; the disease is colorectal carcinoma.